Active Vitamin D Corrects Cerebrovascular Dysfunction and Aberrant Vasopressin Expression in the Hypertension Phenotype of 1α-Hydroxylase Knockout Mice.
{"title":"Active Vitamin D Corrects Cerebrovascular Dysfunction and Aberrant Vasopressin Expression in the Hypertension Phenotype of 1α-Hydroxylase Knockout Mice.","authors":"Wei Zhang, Yingying Hu, Luqing Zhang, Ping Dong, Dongmei Li, Ronghui DU","doi":"10.3177/jnsv.71.290","DOIUrl":null,"url":null,"abstract":"<p><p>Vitamin D has a protective effect on the brain under hypertensive conditions. Studies have shown that 1,25-dihydroxyvitamin D<sub>3</sub> (1,25(OH)<sub>2</sub>D<sub>3</sub>) can negatively regulate hypertension and central renin-angiotensin system activation through a central anti-oxidative mechanism in 1α-hydroxylase knockout mice. To confirm whether endogenous or exogenous 1,25(OH)<sub>2</sub>D<sub>3</sub> deficiency or supplementation alters cerebrovascular function and vasopressin expression through anti-oxidation, researchers provided 1α(OH)ase<sup>-/-</sup> mice and their wild-type littermates with regular diet, a high-calcium, high-phosphorus rescue diet with N-acetyl-L-cysteine supplementation, or 1,25(OH)<sub>2</sub>D<sub>3</sub> subcutaneous injection. The results showed that the hypertension phenotype was present in the 1α(OH)ase<sup>-/-</sup> mice, with upregulated vasopressin expression and increased brain/blood oxidative stress. These pathologic changes were corrected by 1,25(OH)<sub>2</sub>D<sub>3</sub> or N-acetyl-L-cysteine plus rescue diet. The findings suggest that 1,25(OH)<sub>2</sub>D<sub>3</sub> may be a promising protective intervention to reduce brain impairment induced by oxidative stress in the hypertension phenotype of 1α(OH)ase<sup>-/-</sup> mice.</p>","PeriodicalId":16624,"journal":{"name":"Journal of nutritional science and vitaminology","volume":"71 4","pages":"290-299"},"PeriodicalIF":1.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of nutritional science and vitaminology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3177/jnsv.71.290","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Vitamin D has a protective effect on the brain under hypertensive conditions. Studies have shown that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) can negatively regulate hypertension and central renin-angiotensin system activation through a central anti-oxidative mechanism in 1α-hydroxylase knockout mice. To confirm whether endogenous or exogenous 1,25(OH)2D3 deficiency or supplementation alters cerebrovascular function and vasopressin expression through anti-oxidation, researchers provided 1α(OH)ase-/- mice and their wild-type littermates with regular diet, a high-calcium, high-phosphorus rescue diet with N-acetyl-L-cysteine supplementation, or 1,25(OH)2D3 subcutaneous injection. The results showed that the hypertension phenotype was present in the 1α(OH)ase-/- mice, with upregulated vasopressin expression and increased brain/blood oxidative stress. These pathologic changes were corrected by 1,25(OH)2D3 or N-acetyl-L-cysteine plus rescue diet. The findings suggest that 1,25(OH)2D3 may be a promising protective intervention to reduce brain impairment induced by oxidative stress in the hypertension phenotype of 1α(OH)ase-/- mice.
期刊介绍:
The Journal of Nutritional Science and Vitaminology is an international medium publishing in English of original work in all branches of nutritional science, food science and vitaminology from any country.
Manuscripts submitted for publication should be as concise as possible and must be based on the results of original research or of original interpretation of existing knowledge not previously published. Although data may have been reported, in part, in preliminary or
abstract form, a full report of such research is unacceptable if it has been or will be submitted for consideration by another journal.